BFA
KURA icon

BlackRock Fund Advisors’s Kura Oncology KURA Stock Holding History

BlackRock Fund Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$212K Buy
35,904
+882
+3% +$4.73K ﹤0.01% 3409
2016
Q3 		$219K Sell
35,022
-198
-0.6% -$1K ﹤0.01% 3418
2016
Q2 		$95K Buy
35,220
+34,130
+3,131% +$106K ﹤0.01% 3684
2016
Q1 		$4K Buy
1,090
+232
+27% +$1.1K ﹤0.01% 4122
2015
Q4 		$7K Buy
+858
New +$6.75K ﹤0.01% 4072

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Fund Advisors's KURA Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Kura Oncology (KURA) stake by 2.5% in Q4 2016, buying an estimated $4.73K and bringing the position to 35,904 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #3409.

BlackRock Fund Advisors first reported a position in KURA in Q4 2015 and has held it in 5 quarters since. The position peaked at $219K in Q3 2016. 30 funds tracked by Wall St. Rank hold KURA as of Q4 2016.

  • BlackRock Fund Advisors held 35,904 shares of Kura Oncology worth $212K as of Q4 2016.
  • BlackRock Fund Advisors bought 882 Kura Oncology shares in Q4 2016, an estimated $4.73K.
  • Kura Oncology made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3409 holding.
  • BlackRock Fund Advisors first reported a position in Kura Oncology in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Fund Advisors's Kura Oncology position peaked at $219K in Q3 2016.
  • 30 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.